117 related articles for article (PubMed ID: 2179788)
1. Physiology and treatment of hot flushes.
Ravnikar V
Obstet Gynecol; 1990 Apr; 75(4 Suppl):3S-8S; discussion 15S-17S. PubMed ID: 2179788
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal women without previous or current vasomotor symptoms do not flush after abruptly abandoning estrogen replacement therapy.
Hammar M; Ekblad S; Lönnberg B; Berg G; Lindgren R; Wyon Y
Maturitas; 1999 Jan; 31(2):117-22. PubMed ID: 10227004
[TBL] [Abstract][Full Text] [Related]
3. Oral medroxyprogesterone in the treatment of postmenopausal symptoms.
Schiff I; Tulchinsky D; Cramer D; Ryan KJ
JAMA; 1980 Sep; 244(13):1443-5. PubMed ID: 6775094
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of the surgical menopause syndrome with depot medroxyprogesterone acetate and its objective evaluation testing the reaction of the anterior pituitary gland to stimulation with gonadotropin-releasing hormone].
Boschitsch E; Gitsch E; Spona J
Wien Klin Wochenschr; 1983 Oct; 95(20):718-24. PubMed ID: 6229096
[TBL] [Abstract][Full Text] [Related]
5. Differences in the ratio of bioactive to immunoreactive serum luteinizing hormone during vasomotor flushes and hormonal therapy in postmenopausal women.
Chang SP; Shoupe D; Kletzky OA; Lobo RA
J Clin Endocrinol Metab; 1984 May; 58(5):925-9. PubMed ID: 6323519
[TBL] [Abstract][Full Text] [Related]
6. The effect of various drugs with neuroendocrine activity and transdermal estradiol on plasma gonadotropin concentrations after ovariectomy in reproductive-aged women.
Nappi C; Petraglia F; de Chiara BM; Genazzani AD; Montemagno R; Genazzani AR; Montemagno U
Acta Obstet Gynecol Scand; 1991; 70(6):435-9. PubMed ID: 1763606
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.
Rochira V; Zirilli L; Genazzani AD; Balestrieri A; Aranda C; Fabre B; Antunez P; Diazzi C; Carani C; Maffei L
Eur J Endocrinol; 2006 Oct; 155(4):513-22. PubMed ID: 16990650
[TBL] [Abstract][Full Text] [Related]
8. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
[TBL] [Abstract][Full Text] [Related]
9. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with transcutaneous estradiol and oral medroxyprogesterone acetate.
Pedersen OD; Jensen HK
Acta Obstet Gynecol Scand; 1992 Dec; 71(8):593-8. PubMed ID: 1336917
[TBL] [Abstract][Full Text] [Related]
11. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
12. [Vasomotor sudden flushes (author's transl)].
Rotman J
Sem Hop; 1980 Sep 18-25; 56(33-36):1353-5. PubMed ID: 6252626
[TBL] [Abstract][Full Text] [Related]
13. Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period.
Hagen C; Christensen MS; Christiansen C; Stocklund KE; Transbøl I
Acta Obstet Gynecol Scand; 1982; 61(3):237-41. PubMed ID: 6812385
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of follicle-stimulating hormone secretion by estradiol. Mechanism for modulation of gonadotropin responses to low dose pulses of gonadotropin-releasing hormone.
Marshall JC; Case GD; Valk TW; Corley KP; Sauder SE; Kelch RP
J Clin Invest; 1983 Feb; 71(2):248-57. PubMed ID: 6401767
[TBL] [Abstract][Full Text] [Related]
15. Endocrinological basis of hot flushes.
Bider D; Mashiach S; Serr DM; Ben-Rafael Z
Obstet Gynecol Surv; 1989 Jul; 44(7):495-9. PubMed ID: 2662075
[TBL] [Abstract][Full Text] [Related]
16. Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes.
Albrecht BH; Schiff I; Tulchinsky D; Ryan KJ
Am J Obstet Gynecol; 1981 Mar; 139(6):631-5. PubMed ID: 7211966
[TBL] [Abstract][Full Text] [Related]
17. The effects of progestins on vasomotor flushes.
Schiff I
J Reprod Med; 1982 Aug; 27(8 Suppl):498-502. PubMed ID: 7131442
[TBL] [Abstract][Full Text] [Related]
18. Menopausal hot flushes and night sweats: where are we now?
Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
[TBL] [Abstract][Full Text] [Related]
19. The relation of physiological changes to subjective symptoms in postmenopausal women with and without hot flushes.
Mashchak CA; Kletzky OA; Artal R; Mishell DR
Maturitas; 1984 Dec; 6(4):301-8. PubMed ID: 6533433
[TBL] [Abstract][Full Text] [Related]
20. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
Chandeying V; Sangthawan M
J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
